Microbix Biosystems Inc. (TSX:MBX)

Microbix Biosystems Statistics

Total Valuation

TSX:MBX has a market cap or net worth of CAD 33.25 million. The enterprise value is 31.02 million.

Market Cap	33.25M
Enterprise Value	31.02M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:MBX has 138.55 million shares outstanding. The number of shares has increased by 1.38% in one year.

Current Share Class	138.55M
Shares Outstanding	138.55M
Shares Change (YoY)	+1.38%
Shares Change (QoQ)	+2.08%
Owned by Insiders (%)	16.34%
Owned by Institutions (%)	0.43%
Float	115.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.98
PB Ratio	1.25
P/TBV Ratio	1.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.27
EV / Sales	1.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.32

Financial Position

The company has a current ratio of 7.51, with a Debt / Equity ratio of 0.26.

Current Ratio	7.51
Quick Ratio	4.26
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-1.62
Interest Coverage	-3.71

Financial Efficiency

Return on equity (ROE) is -15.39% and return on invested capital (ROIC) is -15.39%.

Return on Equity (ROE)	-15.39%
Return on Assets (ROA)	-5.93%
Return on Invested Capital (ROIC)	-15.39%
Return on Capital Employed (ROCE)	-10.75%
Weighted Average Cost of Capital (WACC)	7.16%
Revenue Per Employee	167,603
Profits Per Employee	-42,700
Employee Count	70
Asset Turnover	0.44
Inventory Turnover	1.09

Taxes

Income Tax	-55,726
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.83% in the last 52 weeks. The beta is 0.38, so TSX:MBX's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-47.83%
50-Day Moving Average	0.23
200-Day Moving Average	0.26
Relative Strength Index (RSI)	55.97
Average Volume (20 Days)	38,817

Short Selling Information

The latest short interest is 11,447, so 0.01% of the outstanding shares have been sold short.

Short Interest	11,447
Short Previous Month	4,761
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:MBX had revenue of CAD 16.76 million and -4.27 million in losses. Loss per share was -0.03.

Revenue	16.76M
Gross Profit	7.83M
Operating Income	-3.60M
Pretax Income	-4.33M
Net Income	-4.27M
EBITDA	-2.24M
EBIT	-3.60M
Loss Per Share	-0.03

Balance Sheet

The company has 9.10 million in cash and 6.87 million in debt, with a net cash position of 2.23 million or 0.02 per share.

Cash & Cash Equivalents	9.10M
Total Debt	6.87M
Net Cash	2.23M
Net Cash Per Share	0.02
Equity (Book Value)	26.61M
Book Value Per Share	0.19
Working Capital	19.97M

Cash Flow

In the last 12 months, operating cash flow was -3.48 million and capital expenditures -764,611, giving a free cash flow of -4.24 million.

Operating Cash Flow	-3.48M
Capital Expenditures	-764,611
Free Cash Flow	-4.24M
FCF Per Share	-0.03

Margins

Gross margin is 46.74%, with operating and profit margins of -21.49% and -25.48%.

Gross Margin	46.74%
Operating Margin	-21.49%
Pretax Margin	-25.81%
Profit Margin	-25.48%
EBITDA Margin	-13.39%
EBIT Margin	-21.49%
FCF Margin	n/a

Dividends & Yields

TSX:MBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.38%
Shareholder Yield	-1.38%
Earnings Yield	-12.84%
FCF Yield	-12.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:MBX has an Altman Z-Score of 2.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.1
Piotroski F-Score	3